在慢性阻塞性肺部疾病中,提奥托的启动和痴呆风险
Che-Yuan Wu1,2, Tetyana Kendzerska3,4,5, Christa Wang6
1Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada.
JAMA internal medicine
|May 19, 2025
概括
长期作用的肌肉抗剂 (tiotropium) 显示,COPD患者的痴呆风险略有增加. 与tiotropium相比,这种风险增加被认为具有可疑的临床重要性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 老年病的医生 老年病的医生
- 神经学 神经学
背景情况:
- 长效肌肉抗剂 (LAMA),如铁,是COPD的支气管扩展剂.
- 关于LAMAs的中央抗胆固醇作用和痴呆症风险的证据有限.
研究的目的:
- 在老年COPD患者中调查启动tiotropium和痴呆风险之间的关联.
主要方法:
- 在加拿大安大略省使用行政数据库进行基于人口的队列研究.
- 与长效β2-激动剂加上吸入性皮质类固醇 (LABA-ICS) 用户 (年龄≥66岁) 进行tiotropium单疗的新用户的比较.
- 使用经过验证的痴呆症算法和1年的滞后时间,对患者进行了长达10年的跟踪.
主要成果:
- 与LABA-ICS相比,启动tiotropium与痴呆风险的小幅增加有关 (HR:1.09;IRD:每1000人年2.3).
- 第二次处理分析没有显示出显著的关联.
结论:
- 提奥对痴呆症风险的绝对增加很小,并且具有可疑的临床意义.
- 确定的tiotropium的临床益处可能会超过这种小的潜在风险.
更多相关视频
相关概念视频
01:24Parkinson's Disease: Treatment
178
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
178
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:26COPD: Management Using Bronchodilators and Corticosteroids
170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
01:22Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
01:20COPD: Pathogenesis and Clinical Features
223
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
223